Interneuron epigenomes during the critical period of cortical plasticity: Implications for schizophrenia

Neurobiology of Learning and Memory

Volumn 124, Issue , 2015, Pages 104-110

  Morishita, Hirofumi ^a   Kundakovic, Marija ^a   Bicks, Lucy ^a   Mitchell, Amanda ^a   Akbarian, Schahram ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cortical plasticity; Critical period; Epigenome; Parvalbuminergic interneuron; Schizophrenia

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 4; GLUTAMATE DECARBOXYLASE 67; 4 AMINOBUTYRIC ACID RECEPTOR; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 1; PARVALBUMIN;

DNA METHYLATION; DOWN REGULATION; ENHANCER REGION; EPIGENETICS; ERBB4 GENE; GAD1 GENE; GAD67 GENE; GENE; GENE DISRUPTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; HUMAN; INTERNEURON; NERVE CELL PLASTICITY; NONHUMAN; PARVALBUMINERGIC INTERNEURON; PREFRONTAL CORTEX; PROMOTER REGION; PV GENE; REVIEW; SCHIZOPHRENIA; VISUAL CORTEX; ANIMAL; BRAIN CORTEX; DISEASE MODEL; GENETIC EPIGENESIS; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME FACTOR;

ANIMALS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DNA METHYLATION; EPIGENESIS, GENETIC; GABAERGIC NEURONS; GLUTAMATE DECARBOXYLASE; HUMANS; INTERNEURONS; NEURONAL PLASTICITY; PARVALBUMINS; PREFRONTAL CORTEX; SCHIZOPHRENIA; TIME FACTORS; VISUAL CORTEX;

EID: 84941259756     PISSN: 10747427     EISSN: 10959564     Source Type: Journal    
DOI: 10.1016/j.nlm.2015.03.005     Document Type: Review

References (114)

1. Aberg K.A., McClay J.L., Nerella S., Clark S., Kumar G., Chen W., et al. Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults. JAMA Psychiatry 2014.
2. Akbarian S., Huang H.S. Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Research Reviews 2006, 52:293-304.
3. Andreassen O.A., Thompson W.K., Dale A.M. Boosting the power of schizophrenia genetics by leveraging new statistical tools. Schizophrenia Bulletin 2014, 40:13-17.
4. Aton S.J., Broussard C., Dumoulin M., Seibt J., Watson A., Coleman T., et al. Visual experience and subsequent sleep induce sequential plastic changes in putative inhibitory and excitatory cortical neurons. Proceedings of the National Academy of Sciences, USA 2013, 110:3101-3106.
5. Auta J., Smith R.C., Dong E., Tueting P., Sershen H., Boules S., et al. DNA-methylation gene network dysregulation in peripheral blood lymphocytes of schizophrenia patients. Schizophrenia Research 2013, 150:312-318.
6. Bagot R.C., Labonte B., Pena C.J., Nestler E.J. Epigenetic signaling in psychiatric disorders: stress and depression. Dialogues in Clinical Neuroscience 2014, 16:281-295.
7. Behan A.T., Hryniewiecka M., O'Tuathaigh C.M., Kinsella A., Cannon M., Karayiorgou M., et al. Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice. impact on indices of dopaminergic, endocannabinoid and GABAergic pathways. Neuropsychopharmacology 2012, 37:1773-1783.
8. Behrens M.M., Ali S.S., Dao D.N., Lucero J., Shekhtman G., Quick K.L., et al. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 2007, 318:1645-1647.
9. Behrens M.M., Ali S.S., Dugan L.L. Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. Journal of Neuroscience 2008, 28:13957-13966.
10. Belforte J.E., Zsiros V., Sklar E.R., Jiang Z., Yu G., Li Y., et al. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nature Neuroscience 2010, 13:76-83.
11. Bernstein B.E., Birney E., Dunham I., Green E.D., Gunter C., Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
12. Berretta S. Extracellular matrix abnormalities in schizophrenia. Neuropharmacology 2012, 62:1584-1597.
13. Bharadwaj R., Jiang Y., Mao W., Jakovcevski M., Dincer A., Krueger W., et al. Conserved chromosome 2q31 conformations are associated with transcriptional regulation of GAD1 GABA synthesis enzyme and altered in prefrontal cortex of subjects with schizophrenia. Journal of Neuroscience 2013, 33:11839-11851.
14. Cabungcal J.H., Counotte D.S., Lewis E.M., Tejeda H.A., Piantadosi P., Pollock C., et al. Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia. Neuron 2014, 83:1073-1084.
15. Cabungcal J.H., Steullet P., Kraftsik R., Cuenod M., Do K.Q. Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine. Biological Psychiatry 2013, 73:574-582.
16. Cabungcal J.H., Steullet P., Morishita H., Kraftsik R., Cuenod M., Hensch T.K., et al. Perineuronal nets protect fast-spiking interneurons against oxidative stress. Proceedings of the National Academy of Sciences, USA 2013, 110:9130-9135.
17. Catts V.S., Fung S.J., Long L.E., Joshi D., Vercammen A., Allen K.M., et al. Rethinking schizophrenia in the context of normal neurodevelopment. Frontiers in Cellular Neuroscience 2013, 7:60.
18. Chao H.T., Chen H., Samaco R.C., Xue M., Chahrour M., Yoo J., et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010, 468:263-269.
19. Chattopadhyaya B., Di Cristo G., Wu C.Z., Knott G., Kuhlman S., Fu Y., et al. GAD67-mediated GABA synthesis and signaling regulate inhibitory synaptic innervation in the visual cortex. Neuron 2007, 54:889-903.
20. Cheung I., Shulha H.P., Jiang Y., Matevossian A., Wang J., Weng Z., et al. Developmental regulation and individual differences of neuronal H3K4me3 epigenomes in the prefrontal cortex. Proceedings of the National Academy of Sciences, USA 2010, 107:8824-8829.
21. Cho R.Y., Konecky R.O., Carter C.S. Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proceedings of the National Academy of Sciences, USA 2006, 103:19878-19883.
22. Curley A.A., Eggan S.M., Lazarus M.S., Huang Z.J., Volk D.W., Lewis D.A. Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: implications for schizophrenia. Neurobiology of Diseases 2013, 50:179-186.
23. Del Pino I., Garcia-Frigola C., Dehorter N., Brotons-Mas J.R., Alvarez-Salvado E., Martinez de Lagran M., et al. Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. Neuron 2013, 79:1152-1168.
24. Dorph-Petersen K.A., Lewis D.A. Stereological approaches to identifying neuropathology in psychosis. Biological Psychiatry 2011, 69:113-126.
25. Espinosa J.S., Stryker M.P. Development and plasticity of the primary visual cortex. Neuron 2012, 75:230-249.
26. Fagiolini M., Fritschy J.M., Low K., Mohler H., Rudolph U., Hensch T.K. Specific GABAA circuits for visual cortical plasticity. Science 2004, 303:1681-1683.
27. Fischer A., Sananbenesi F., Mungenast A., Tsai L.H. Targeting the correct HDAC(s) to treat cognitive disorders. Trends in Pharmacological Sciences 2010, 31:605-617.
28. Fung S.J., Fillman S.G., Webster M.J., Shannon Weickert C. Schizophrenia and bipolar disorder show both common and distinct changes in cortical interneuron markers. Schizophrenia Research 2014, 155:26-30.
29. Fung S.J., Webster M.J., Sivagnanasundaram S., Duncan C., Elashoff M., Weickert C.S. Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. American Journal of Psychiatry 2010, 167:1479-1488.
30. Gandhi S.P., Yanagawa Y., Stryker M.P. Delayed plasticity of inhibitory neurons in developing visual cortex. Proceedings of the National Academy of Sciences, USA 2008, 105:16797-16802.
31. Gavin D.P., Kartan S., Chase K., Jayaraman S., Sharma R.P. Histone deacetylase inhibitors and candidate gene expression: an in vivo and in vitro approach to studying chromatin remodeling in a clinical population. Journal of Psychiatric Research 2009, 43:870-876.
32. Georgiev D., Arion D., Enwright J.F., Kikuchi M., Minabe Y., Corradi J.P., et al. Lower gene expression for KCNS3 potassium channel subunit in parvalbumin-containing neurons in the prefrontal cortex in schizophrenia. American Journal of Psychiatry 2014, 171:62-71.
33. Gogolla N., Leblanc J.J., Quast K.B., Sudhof T.C., Fagiolini M., Hensch T.K. Common circuit defect of excitatory-inhibitory balance in mouse models of autism. Journal of Neurodevelopmental Disorders 2009, 1:172-181.
34. Gonzalez-Burgos G., Fish K.N., Lewis D.A. GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Neural Plasticity 2011, 2011:723184.
35. Grayson D.R., Guidotti A. The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. Neuropsychopharmacology 2013, 38:138-166.
36. Gruber A.J., Calhoon G.G., Shusterman I., Schoenbaum G., Roesch M.R., O'Donnell P. More is less: a disinhibited prefrontal cortex impairs cognitive flexibility. Journal of Neuroscience 2010, 30:17102-17110.
37. Guidotti A., Dong E., Tueting P., Grayson D.R. Modeling the molecular epigenetic profile of psychosis in prenatally stressed mice. Progress in Molecular Biology and Translational Science 2014, 128:89-101.
38. Hashimoto T., Bergen S.E., Nguyen Q.L., Xu B., Monteggia L.M., Pierri J.N., et al. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. Journal of Neuroscience 2005, 25:372-383.
39. Hashimoto T., Volk D.W., Eggan S.M., Mirnics K., Pierri J.N., Sun Z., et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. Journal of Neuroscience 2003, 23:6315-6326.
40. Hengen K.B., Lambo M.E., Van Hooser S.D., Katz D.B., Turrigiano G.G. Firing rate homeostasis in visual cortex of freely behaving rodents. Neuron 2013, 80:335-342.
41. Hensch T.K. Critical period regulation. Annual Review of Neuroscience 2004, 27:549-579.
42. Hensch T.K. Critical period plasticity in local cortical circuits. Nature Reviews Neuroscience 2005, 6:877-888.
43. Hensch T.K., Fagiolini M., Mataga N., Stryker M.P., Baekkeskov S., Kash S.F. Local GABA circuit control of experience-dependent plasticity in developing visual cortex. Science 1998, 282:1504-1508.
44. Hirano Y., Oribe N., Kanba S., Onitsuka T., Nestor P.G., Spencer K.M. Spontaneous gamma activity in schizophrenia. JAMA Psychiatry 2015.
45. Hofer S.B., Mrsic-Flogel T.D., Bonhoeffer T., Hubener M. Prior experience enhances plasticity in adult visual cortex. Nature Neuroscience 2006, 9:127-132.
46. Hoftman G.D., Lewis D.A. Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia. Schizophrenia Bulletin 2011, 37:493-503.
47. Huang H.S., Akbarian S. GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia. PLoS ONE 2007, 2:e809.
48. Huang H.S., Matevossian A., Whittle C., Kim S.Y., Schumacher A., Baker S.P., et al. Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. Journal of Neuroscience 2007, 27:11254-11262.
49. Hyde T.M., Lipska B.K., Ali T., Mathew S.V., Law A.J., Metitiri O.E., et al. Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia. Journal of Neuroscience 2011, 31:11088-11095.
50. Ikegame T., Bundo M., Murata Y., Kasai K., Kato T., Iwamoto K. DNA methylation of the BDNF gene and its relevance to psychiatric disorders. Journal of Human Genetics 2013, 58:434-438.
51. Inan M., Petros T.J., Anderson S.A. Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia. Neurobiology of Diseases 2013, 53:36-48.
52. Insel T.R. Rethinking schizophrenia. Nature 2010, 468:187-193.
53. Iwai Y., Fagiolini M., Obata K., Hensch T.K. Rapid critical period induction by tonic inhibition in visual cortex. Journal of Neuroscience 2003, 23:6695-6702.
54. Jaaro-Peled H., Hayashi-Takagi A., Seshadri S., Kamiya A., Brandon N.J., Sawa A. Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends in Neurosciences 2009, 32:485-495.
55. Jakovcevski M., Bharadwaj R., Straubhaar J., Gao G., Gavin D.P., Jakovcevski I., et al. Prefrontal cortical dysfunction after overexpression of histone deacetylase 1. Biological Psychiatry 2013, 74:696-705.
56. Jeevakumar V., Driskill C., Paine A., Sobhanian M., Vakil H., Morris B., et al. Ketamine administration during the second postnatal week induces enduring schizophrenia-like behavioral symptoms and reduces parvalbumin expression in the medial prefrontal cortex of adult mice. Behavioural Brain Research 2015.
57. Jeevakumar V., Kroener S. Ketamine administration during the second postnatal week alters synaptic properties of fast-spiking interneurons in the medial prefrontal cortex of adult mice. Cerebral Cortex 2014.
58. Jiang Y., Matevossian A., Huang H.S., Straubhaar J., Akbarian S. Isolation of neuronal chromatin from brain tissue. BMC Neuroscience 2008, 9:42.
59. Kameyama K., Sohya K., Ebina T., Fukuda A., Yanagawa Y., Tsumoto T. Difference in binocularity and ocular dominance plasticity between GABAergic and excitatory cortical neurons. Journal of Neuroscience 2010, 30:1551-1559.
60. Karam C.S., Ballon J.S., Bivens N.M., Freyberg Z., Girgis R.R., Lizardi-Ortiz J.E., et al. Signaling pathways in schizophrenia: emerging targets and therapeutic strategies. Trends in Pharmacological Sciences 2010, 31:381-390.
61. Katagiri H., Fagiolini M., Hensch T.K. Optimization of somatic inhibition at critical period onset in mouse visual cortex. Neuron 2007, 53:805-812.
62. Knudsen E.I. Sensitive periods in the development of the brain and behavior. Journal of Cognitive Neuroscience 2004, 16:1412-1425.
63. Konradi C., Yang C.K., Zimmerman E.I., Lohmann K.M., Gresch P., Pantazopoulos H., et al. Hippocampal interneurons are abnormal in schizophrenia. Schizophrenia Research 2011, 131:165-173.
64. Kuhlman S.J., Olivas N.D., Tring E., Ikrar T., Xu X., Trachtenberg J.T. A disinhibitory microcircuit initiates critical-period plasticity in the visual cortex. Nature 2013, 501:543-546.
65. Kurita M., Holloway T., Garcia-Bea A., Kozlenkov A., Friedman A.K., Moreno J.L., et al. HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nature Neuroscience 2012, 15:1245-1254.
66. Lazarus M.S., Krishnan K., Huang Z.J. GAD67 deficiency in parvalbumin interneurons produces deficits in inhibitory transmission and network disinhibition in mouse prefrontal cortex. Cerebral Cortex 2013.
67. LeBlanc J.J., Fagiolini M. Autism: a "critical period" disorder?. Neural Plasticity 2011, 2011:921680.
68. Levelt C.N., Hubener M. Critical-period plasticity in the visual cortex. Annual Review of Neuroscience 2012, 35:309-330.
69. Lewis D.A. Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia. Current Opinion in Neurobiology 2014, 26:22-26.
70. Lewis D.A., Hashimoto T., Volk D.W. Cortical inhibitory neurons and schizophrenia. Nature Reviews Neuroscience 2005, 6:312-324.
71. Lodge D.J., Behrens M.M., Grace A.A. A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. Journal of Neuroscience 2009, 29:2344-2354.
72. Lopez-Atalaya J.P., Barco A. Can changes in histone acetylation contribute to memory formation?. Trends in Genetics 2014, 30:529-539.
73. Mauney S.A., Athanas K.M., Pantazopoulos H., Shaskan N., Passeri E., Berretta S., et al. Developmental pattern of perineuronal nets in the human prefrontal cortex and their deficit in schizophrenia. Biological Psychiatry 2013, 74:427-435.
74. McGee A.W., Yang Y., Fischer Q.S., Daw N.W., Strittmatter S.M. Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor. Science 2005, 309:2222-2226.
75. Mellios N., Huang H.S., Baker S.P., Galdzicka M., Ginns E., Akbarian S. Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biological Psychiatry 2009, 65:1006-1014.
76. Mitchell R.M., Janssen M.J., Karavanova I., Vullhorst D., Furth K., Makusky A., et al. ErbB4 reduces synaptic GABAA currents independent of its receptor tyrosine kinase activity. Proceedings of the National Academy of Sciences, USA 2013, 110:19603-19608.
77. Morishita H., Cabungcal J.-H., Chen Y., Do K.Q., Hensch T.K. Prolonged period of cortical plasticity upon redox dysregulation in fast-spiking interneurons. Biological Psychiatry 2015, 10.1016/j.biopsych.2014.12.026.
78. Morishita H., Hensch T.K. Critical period revisited: impact on vision. Current Opinion in Neurobiology 2008, 18:101-107.
79. Morishita H., Miwa J.M., Heintz N., Hensch T.K. Lynx1, a cholinergic brake, limits plasticity in adult visual cortex. Science 2010, 330:1238-1240.
80. Nabel E.M., Morishita H. Regulating critical period plasticity: insight from the visual system to fear circuitry for therapeutic interventions. Frontiers in Psychiatry 2013, 4:146.
81. Neddens J., Fish K.N., Tricoire L., Vullhorst D., Shamir A., Chung W., et al. Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia. Biological Psychiatry 2011, 70:636-645.
82. O'Donnell P. Adolescent onset of cortical disinhibition in schizophrenia: insights from animal models. Schizophrenia Bulletin 2011, 37:484-492.
83. Pantazopoulos H., Woo T.U., Lim M.P., Lange N., Berretta S. Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia. Archives of General Psychiatry 2010, 67:155-166.
84. Peixoto L., Abel T. The role of histone acetylation in memory formation and cognitive impairments. Neuropsychopharmacology 2013, 38:62-76.
85. Pizzorusso T., Medini P., Berardi N., Chierzi S., Fawcett J.W., Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 2002, 298:1248-1251.
86. Powell S.B., Sejnowski T.J., Behrens M.M. Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia. Neuropharmacology 2012, 62:1322-1331.
87. Putignano E., Lonetti G., Cancedda L., Ratto G., Costa M., Maffei L., et al. Developmental downregulation of histone posttranslational modifications regulates visual cortical plasticity. Neuron 2007, 53:747-759.
88. Rico B., Marin O. Neuregulin signaling, cortical circuitry development and schizophrenia. Current Opinion in Genetics & Development 2011, 21:262-270.
89. Rodriguez-Murillo L., Gogos J.A., Karayiorgou M. The genetic architecture of schizophrenia: new mutations and emerging paradigms. Annual Review of Medicine 2012, 63:63-80.
90. Rudy B., Fishell G., Lee S., Hjerling-Leffler J. Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons. Developmental Neurobiology 2011, 71:45-61.
91. Schmidt M.J., Mirnics K. Modeling interneuron dysfunction in schizophrenia. Developmental Neuroscience 2012, 34:152-158.
92. Siegmund K.D., Connor C.M., Campan M., Long T.I., Weisenberger D.J., Biniszkiewicz D., et al. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS ONE 2007, 2:e895.
93. Silingardi D., Scali M., Belluomini G., Pizzorusso T. Epigenetic treatments of adult rats promote recovery from visual acuity deficits induced by long-term monocular deprivation. European Journal of Neuroscience 2010, 31:2185-2192.
94. Stark K.L., Xu B., Bagchi A., Lai W.S., Liu H., Hsu R., et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nature Genetics 2008, 40:751-760.
95. Stephany C.E., Chan L.L., Parivash S.N., Dorton H.M., Piechowicz M., Qiu S., et al. Plasticity of binocularity and visual acuity are differentially limited by nogo receptor. Journal of Neuroscience 2014, 34:11631-11640.
96. Steullet P., Cabungcal J.H., Monin A., Dwir D., O'Donnell P., Cuenod M., et al. Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?. Schizophrenia Research 2014.
97. Sugiyama S., Di Nardo A.A., Aizawa S., Matsuo I., Volovitch M., Prochiantz A., et al. Experience-dependent transfer of Otx2 homeoprotein into the visual cortex activates postnatal plasticity. Cell 2008, 134:508-520.
98. Syken J., Grandpre T., Kanold P.O., Shatz C.J. PirB restricts ocular-dominance plasticity in visual cortex. Science 2006, 313:1795-1800.
99. Takesian A.E., Hensch T.K. Balancing plasticity/stability across brain development. Progress in Brain Research 2013, 207:3-34.
100. Tang B., Dean B., Thomas E.A. Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders. Translational Psychiatry 2011, 1:e64.
101. Thomases D.R., Cass D.K., Tseng K.Y. Periadolescent exposure to the NMDA receptor antagonist MK-801 impairs the functional maturation of local GABAergic circuits in the adult prefrontal cortex. Journal of Neuroscience 2013, 33:26-34.
102. Thompson Ray M., Weickert C.S., Wyatt E., Webster M.J. Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. Journal of Psychiatry and Neuroscience 2011, 36:195-203.
103. Uchida T., Furukawa T., Iwata S., Yanagawa Y., Fukuda A. Selective loss of parvalbumin-positive GABAergic interneurons in the cerebral cortex of maternally stressed Gad1-heterozygous mouse offspring. Translational Psychiatry 2014, 4:e371.
104. Uhlhaas P.J., Singer W. Oscillations and neuronal dynamics in schizophrenia: the search for basic symptoms and translational opportunities. Biological Psychiatry 2014.
105. Vogel-Ciernia A., Wood M.A. Neuron-specific chromatin remodeling: a missing link in epigenetic mechanisms underlying synaptic plasticity, memory, and intellectual disability disorders. Neuropharmacology 2014, 80:18-27.
106. Volk D.W., Chitrapu A., Edelson J.R., Lewis D.A. Chemokine receptors and cortical interneuron dysfunction in schizophrenia. Schizophrenia Research 2014.
107. Volk D.W., Edelson J.R., Lewis D.A. Cortical inhibitory neuron disturbances in schizophrenia: role of the ontogenetic transcription factor Lhx6. Schizophrenia Bulletin 2014, 40:1053-1061.
108. Volk D.W., Lewis D.A. Prenatal ontogeny as a susceptibility period for cortical GABA neuron disturbances in schizophrenia. Neuroscience 2013, 248:154-164.
109. Volk D.W., Matsubara T., Li S., Sengupta E.J., Georgiev D., Minabe Y., et al. Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. American Journal of Psychiatry 2012, 169:1082-1091.
110. Volk D.W., Matsubara T., Li S., Sengupta E.J., Georgiev D., Minabe Y., et al. Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. American Journal of Psychiatry 2012.
111. Volman V., Behrens M.M., Sejnowski T.J. Downregulation of parvalbumin at cortical GABA synapses reduces network gamma oscillatory activity. Journal of Neuroscience 2011, 31:18137-18148.
112. Yang J.M., Zhang J., Chen X.J., Geng H.Y., Ye M., Spitzer N.C., et al. Development of GABA circuitry of fast-spiking basket interneurons in the medial prefrontal cortex of erbb4-mutant mice. Journal of Neuroscience 2013, 33:19724-19733.
113. Yazaki-Sugiyama Y., Kang S., Cateau H., Fukai T., Hensch T.K. Bidirectional plasticity in fast-spiking GABA circuits by visual experience. Nature 2009, 462:218-221.
114. Yoon J.H., Maddock R.J., Rokem A., Silver M.A., Minzenberg M.J., Ragland J.D., et al. GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression. Journal of Neuroscience 2010, 30:3777-3781.